• news.cision.com/
  • H. Lundbeck A/S/
  • H. Lundbeck, Lundbeck files application for approval of Cipralex® for the treatment of Obsessive-Compulsive Disorder (OCD)
English

H. Lundbeck, Lundbeck files application for approval of Cipralex® for the treatment of Obsessive-Compulsive Disorder (OCD)

Report this content 

                        
H. Lundbeck A/S has filed an application for approval of Cipralex® (escitalopram) for the treatment of OCD in the EU with the health authorities in Sweden, which acts as reference country in the European mutual recognition procedure.




                                            

                

            

        

    

    



    

        
 Subscribe

        

            

        

    


        

            
        

        

            
        

        



    

        
 Documents & Links